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Genetic Ablation of Mast Cells Redefines the
Role of Mast Cells in Skin Wound Healing and
Bleomycin-Induced Fibrosis
Sebastian Willenborg1, Beate Eckes1, Ju¨rgen Brinckmann2,3, Thomas Krieg1,4,5, Ari Waisman6,
Karin Hartmann1, Axel Roers7 and Sabine A. Eming1,4,5
Conclusive evidence for the impact of mast cells (MCs) in skin repair is still lacking. Studies in mice examining
the role of MC function in the physiology and pathology of skin regenerative processes have obtained
contradictory results. To clarify the specific role of MCs in regenerative conditions, here we used a recently
developed genetic mouse model that allows conditional MC ablation to examine MC-specific functions in skin.
This mouse model is based on the cell type–specific expression of Cre recombinase in connective tissue–type
MCs under control of the Mcpt5 promoter and the Cre-inducible diphtheria toxin receptor–mediated cell lineage
ablation by diphtheria toxin. In response to excisional skin injury, genetic ablation of MCs did not affect the
kinetics of reepithelialization, the formation of vascularized granulation tissue, or scar formation. Furthermore,
genetic ablation of MCs failed to prevent the development of skin fibrosis upon bleomycin challenge. The
amount of deposited collagen and the biochemistry of collagen fibril crosslinks within fibrotic lesions were
comparable in MC-depleted and control mice. Collectively, our findings strongly suggest that significant
reduction of MC numbers does not affect skin wound healing and bleomycin-induced fibrosis in mice, and
provide to our knowledge previously unreported insight in the long-debated contribution of MCs in skin
regenerative processes.
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INTRODUCTION
Impaired wound healing and fibrosis of diverse tissues are
leading causes of morbidity and mortality (Wadman, 2005;
Sen et al., 2009). The molecular and cellular events underlying
these processes are not completely understood and require
further analysis to design effective therapeutic approaches.
The physiologic healing response upon excisional skin injury is
initiated by a local, timely limited inflammatory response,
followed by the formation of vascularized granulation
tissue, myofibroblast differentiation, epithelialization, and a
long-lasting phase of tissue maturation (Martin, 1997; Gurtner
et al., 2008). The inflammatory response has potential to cause
severe tissue damage with permanent remodeling of the
extracellular matrix if imbalanced, resulting in uncontrolled
connective tissue deposition and function-impairing scarring
(Eming et al., 2007; Lucas et al., 2010).
Tissue-resident mast cells (MCs) and MC precursors
recruited from the circulation have been implicated in con-
trolling the balance of inflammatory signals directing the
quality of tissue repair and fibrosis. Yet, MC-specific functions
in the physiology and/or pathology of the wound healing
response are not clear. MC accumulation and activation at the
site of skin injury and in fibrotic tissue in humans and mice is
well documented (Yamamoto et al., 1999a; Trautmann et al.,
2000; Weller et al., 2006; Gabrielli et al., 2009). Furthermore,
a recent study in mice suggests that MCs mediate the transition
from scarless to fibrotic healing during fetal development
(Wulff et al., 2012). To investigate the cell-specific impact of
MCs during skin repair, the MC-deficient mouse line
WBB6F1-KitW/KitW-v (W/Wv mice) has been frequently used
(Kitamura et al., 1978). However, independent studies in
tissue repair generated in W/Wv mice resulted in partially
contradictory results. In particular, the impact of MCs on
the inflammatory infiltrate, the kinetics of wound closure,
induction of angiogenesis, and the development of fibrosis are
under debate (Yamamoto et al., 1999b; Egozi et al., 2003;
Nauta et al., 2013). Notably, recent studies revealed that
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W/Wv mice are not only MC deficient but are also
characterized by other complex alterations of their immune
system that might contribute to the phenotypes observed in
specific disease models (Nigrovic et al., 2008). In addition
to MC deficiency, W/Wv mice suffer from anemia and
neutropenia, lack intraepithelial gd T lymphocytes, and are
prone to dermatitis and gastritis (Zhou et al., 2007; Nigrovic
et al., 2008). In fact, recent studies reported on major
differences in the outcome of contact hypersensitivity
responses and antibody-induced arthritis between W/Wv mice
and genetic mouse models of inducible and constitutive MC
ablation (Dudeck et al., 2011; Feyerabend et al., 2011).
To determine the specific role of MCs in skin repair and
fibrosis, here we used a recently developed genetic mouse
model of inducible depletion of connective tissue MCs, in
which no side effects have been described (Dudeck et al.,
2011). Our findings strongly suggest that severe reduction
of MC numbers does not affect skin wound healing and
bleomycin-induced fibrosis in mice.
RESULTS
Depletion of connective tissue–type MCs in wound tissue in
Mcpt5Cre/iDTR mice
To analyze the functional impact of MCs during tissue repair in
the skin, we generated mice in which MCs can be specifically
and inducibly ablated by the application of diphtheria toxin
(DT). This mouse line (Mcpt5Cre/iDTR) was generated by
crossing Cre-inducible human DT-receptor-transgenic mice
(iDTR) to recently generated Mcpt5Cre mice, shown to express
Cre recombinase specifically in connective tissue–type MCs
(Figure 1a) (Buch et al., 2005; Scholten et al., 2008).
To assess specificity and efficiency of Mcpt5Cre-mediated
recombination in wound MCs, we first inflicted full-thickness
excision wounds on the back of Mcpt5Cre/eYFP reporter
mice, in which Cre-mediated excision of a STOP cassette
leads to enhanced yellow fluorescent protein (eYFP) expres-
sion under control of the Rosa26 promoter (Figure 1b).
Immunostainings of wound tissue for MCs (c-kitþ ) and eYFP
showed that eYFP expression within the granulation tissue was
restricted to c-kitþ cells, with most of c-kitþ cells expressing
eYFP (Figure 1c). MC accumulation at the wound site was
sparse within the granulation tissue during the early (day 4)
and mid (day 7) phase of repair (data not shown), and was
detectable in significant numbers at the late stage (day 14)
within the scar tissue (Figure 1c). FACS analysis of wound cell
suspensions isolated from Mcpt5Cre/eYFP reporter mice at day
14 after injury showed that B0.9±0.1% of all wound cells
expressed eYFP and that CD45þ cells represented the major
fraction of eYFPþ cells (Figure 1d). The majority of eYFPþ
CD45þ cells were c-kitþ IgEþ (90.5%), representing connec-
tive tissue MCs. Few eYFPþCD45þ cells were c-kitþ IgE
(7.2%), corresponding to MC precursors or immature MCs.
These findings demonstrate that recombination within the
leukocyte compartment is highly specific for MCs. We
observed a minor fraction of eYFPþCD45 cells (0.1%)
(Figure 1d, lower panel) that failed to express c-kit or Fc
epsilon receptor I and that were sporadically detected in the
hyperproliferative epidermis of day 14 wounds. At this stage,
we cannot explain this observation because keratinocytes are
not known to express Mcpt5. In fact, we never detected
eYFPþ cells in the epidermis of uninjured Mcpt5/eYFP
reporter mice. To investigate the efficiency of Mcpt5Cre-
mediated recombination, we next analyzed eYFP expression
within the population of c-kitþ IgEþ cells. On average,
81.8±5.9% of c-kitþ IgEþ cells expressed eYFP (Figure 1e).
To induce MC depletion in Mcpt5Cre/iDTR mice, we
followed a protocol for DT injections as previously described
(Dudeck et al., 2011). c-kitþ IgEþ MCs in the peritoneal cavity
(Figure 2a) and Giemsaþ MCs in unwounded back skin
(Figure 2b) in DT-injected Mcpt5Cre/iDTR mice were effi-
ciently ablated. Consistent with the quantification of MCs
(eYFP/c-kitþ ) in wound tissue during the time course of
healing in Mcpt5Cre/eYFP reporter mice, analysis of Giemsa-
stained sections in control mice revealed a significant increase
of MCs during the late phase of healing, thereby restoring the
average MC density of unwounded skin (Figure 2d and e). In
contrast, MCs within the granulation (day 7)/scar (day 14)
tissue and in unwounded skin at wound edges in MC-depleted
mice were significantly reduced over the entire time course of
healing when compared with control mice (Figure 2d and e).
Particularly, the combination of systemic (intraperitoneal (i.p.))
and local (intradermal (i.d.)) DT injections after injury
(Figure 2c) leads to severe MC depletion in late-stage wounds.
Reduced DT injections after injury (1 i.p. after injury)
resulted in a mild MC depletion (MC reduction at day 14
after injury: 42.3±13.5%) (Supplementary Figure S1 online).
Efficient ablation of MCs in wound tissue of DT-treated
Mcpt5Cre/iDTR mice through the entire repair response was
confirmed by immunohistochemical staining for c-kit and
Toluidine blue staining (Supplementary Figure S2 online).
MC ablation does not affect the development of granulation
tissue and epithelialization in skin wounds
To examine the functional impact of MCs during the diverse
stages of repair, full-thickness skin wounds were inflicted on
the back of Mcpt5Cre/iDTR and control mice, and at diverse
time points after injury the healing response was assessed by
macroscopical and histological morphometric analyses. MC
depletion was performed following the DT injection regime
outlined in Figure 2c. The macroscopic analysis of wound
closure was comparable in MC-depleted and control mice
(data not shown). Determining the distance between the two
epithelial tips (histological measure for epithelialization)
revealed that the rate of wound closure was not affected by
MC ablation. Figure 3a outlines the key histological features of
an early- and mid-stage wound (Figure 3b). Furthermore, the
kinetics of reepithelialization and development of an early
vascularized granulation tissue were independent of MCs
(Figure 3b). The only significant difference between wound
tissue of MC-depleted and control mice was the increased
distance between the two edges of the panniculus carnosus at
day 3 after injury, indicating a temporary attenuated wound
contraction in MC-depleted mice (Figure 3b and c). The
distance between the two edges of the panniculus carnosus
is regarded as a measure of wound contraction that in rodents
is a combination of contractile myofibroblasts developing
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Figure 1. Gene deletion in Mcpt5Cre/eYFP mice. (a) Generation of Mcpt5Cre/iDTR and (b) Mcpt5Cre/eYFP mice. (c) c-kit/eYFP immunostainings of wound
sections in Mcpt5Cre/eYFP reporter mice at day 14; asterisks indicate c-kitþeYFPþ cells; bar¼ 40mm. (d) Specificity of Mcpt5Cre-mediated recombination: single-
cell suspensions isolated from wounds at day 14 in Mcpt5Cre/eYFP reporter mice were analyzed by flow cytometry. Upper panel: 7-AAD-eYFPþ cells were gated
and quantified; lower panel: 7-AAD-eYFPþCD45þ or 7-AADeYFPþCD45 cells were gated and analyzed for c-kit and surface-bound IgE; each dot represents
one wound (n¼ 4 wounds from 2 mice). (e) Efficiency of Mcpt5Cre-mediated recombination in mast cells (MCs): single-cell suspensions isolated from wounds at
day 14 in Mcpt5Cre/eYFP reporter mice were analyzed by flow cytometry: 7-AADc-kitþ IgEþ cells were gated and analyzed for expression of eYFP; each dot
represents one wound (n¼ 4 wounds from 2 mice). Two independent experiments were performed. 7-AAD, 7-Amino-Actinomycin D; eYFP, enhanced yellow
fluorescent protein; iDTR, inducible diphtheria toxin receptor; Mcpt5, mast cell protease 5; st, scar tissue.
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Figure 2. Efficient MC ablation in Mcpt5Cre/iDTR mice during skin wound healing. (a) Quantification of MCs in the peritoneal cavity after 4 intraperitoneal
(i.p.) injections of DT; each dot represents one mouse (n¼ 4–5 mice per genotype). (b) Quantification of MCs in Giemsa-stained back skin after 4 i.p. injections of
DT; bar¼ 200mm, each dot represents one mouse (n¼ 4–5 mice per genotype). (c) DT injection regime during wound healing. (d) Upper panel, H&E-stained
wound section at day 14 illustrating the distinct areas at the wound site; bar¼500mm; lower panel, quantification of MCs in distinct areas of the wound site in
Giemsa-stained sections; each dot represents one wound (n¼ 6–11 wounds from 3–6 mice per genotype and time point). (e) Representative Giemsa-stained wound
sections at day 14; bar¼40mm. Dotted line underlines hyperproliferative epithelium. d, dermis; DT, diphtheria toxin; e, epidermis; he, hyperproliferative
epithelium; H&E, hematoxylin and eosin; iDTR, inducible diphtheria toxin receptor; MC, mast cell; Mcpt5, mast cell protease 5; pc, panniculus carnosus;
sf, subcutaneous fat tissue; sm, skeletal muscle. **Po0.01, ***Po0.001.
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within the late granulation tissue and contractile effects of the
panniculus carnosus (Martin, 1997). The area of aSMAþ
myofibroblasts, the cellular correlate of granulation tissue
contraction during skin repair, was similar in control and
MC-depleted mice at 4 and 7 days after injury (Figure 3d).
MCs have been frequently associated with the development
of tissue fibrosis. To examine the impact of MCs on scar
development, we characterized the transition of late granula-
tion tissue in scar tissue. Neither the amount of scar tissue was
altered by MC depletion (Figure 3b) nor the number of
aSMAþ myofibroblasts within mid-stage granulation tissue
in controls and MC-depleted animals (Figure 3d). Furthermore,
as revealed by Picrosirius red staining and analysis in
polarized light, MC ablation has no impact on the organiza-
tion and fibrillar structure of collagen in scar formation after
injury (Figure 3e). Notably, to investigate whether the few
MCs still detectable in late-stage day 14 wounds in some DT-
treated Mcpt5Cre/iDTR mice (average o15%), we performed
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Figure 3. Severe reduction of MC numbers does not affect the repair of excision skin injury. (a) Scheme of a wound section following injury: black arrows
indicate tips of the hyperproliferative epithelial tongues, and white arrows indicate ends of the panniculus carnosus. (b) Wound healing parameters in control
and Mcpt5Cre/iDTR mice; each dot represents one wound (n¼6–11 wounds from 3 to 6 mice per genotype and time point), **Po0.01. (c) Representative
H&E-stained wound sections from control and Mcpt5Cre/iDTR mice 3 days after injury; length between the two ends of the panniculus carnosus is depicted;
bar¼ 1 mm. (d) Quantification of aSMA-positive area within the granulation tissue; each dot represents one wound (n¼ 4 wounds from 2 mice per genotype and
time point). (e) Picrosirius red–stained wound sections at day 14 analyzed in polarized light; bar¼ 100mm. d, dermis; e, epidermis; g, granulation tissue; he,
hyperproliferative epithelium; H&E, hematoxylin and eosin; iDTR, inducible diphtheria toxin receptor; MC, mast cell; Mcpt5, mast cell protease 5; pc, panniculus
carnosus; sf, subcutaneous fat tissue; sm, skeletal muscle; aSMA, a-smooth muscle actin.
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DT dosing experiments to correlate MC numbers with the
healing response. Notably, neither a mild (42.3±13.5%) nor a
severe (85.4±6.1%) reduction of wound MCs had any impact
on epithelialization or scar formation (Figure 3b; Supple-
mentary Figure S1B and C online).
Infiltration of leukocytes to the site of skin injury is not altered in
MC-deficient mice
To characterize the impact of MCs on the composition of the
early inflammatory infiltrate during skin repair, wound cell
suspensions isolated from MC-depleted and control mice were
analyzed by flow cytometry at days 2 and 4 after injury. In the
wounds of both control and MC-depleted mice, the relative
and absolute numbers of polymorphonuclear cells (Ly6Gþ
CD11bþ ) significantly decreased from day 2 to 4 after injury
(Figure 4a), whereas the relative number of macrophages (F4/
80þCD11bþ ) significantly increased during this period
(Figure 4b). Results from FACS analysis in wound tissues were
confirmed by immunohistochemical stainings (data not
shown). Both analyses showed that infiltration of leukocytes
to the site of injury was not altered by MC depletion.
Genetic ablation of MCs fails to prevent bleomycin-induced skin
fibrosis in mice
To investigate the functional impact of MCs on the develop-
ment of skin fibrosis, the back skin of MC-depleted and
control mice was challenged with repetitive i.d. injections of
bleomycin. To maintain MC ablation over the time course of
bleomycin challenge, i.p. DT injections were continued in
weekly intervals (Figure 5a). Analysis of Giemsa-stained tissue
sections in control mice revealed a major accumulation of
MCs within fibrotic lesions (skin area with maximal dermal
thickening) and within the adjacent skin (fibrotic edge
Figure 5b). At both time points, the accumulation of MCs
was more severe at the margins than within the fibrotic lesions
itself in control mice (Figure 5b). MC depletion was highly
efficient within fibrotic lesions and margins in DT-treated
Mcpt5Cre/iDTR mice versus control mice over the time course
of the experiment (Figure 5b).
To examine whether MC accumulation in skin during
bleomycin challenge correlated with the development of skin
fibrosis, hematoxylin and eosin–stained sections of fibrotic
tissues from MC-depleted and control mice (iDTR mice treated
with NaCl or bleomycin) were subjected to histological
quantification. The findings revealed a massive increase of
dermal thickening in fibrotic lesions of bleomycin-challenged
control and MC-depleted mice at days 14 and 28 when
compared with NaCl-treated control mice (Figure 6a and b).
Picrosirius red staining of tissue sections and analysis in
polarized light showed that the collagen bundles within
fibrotic lesions of bleomycin-treated mice appeared thicker
(indicated by arrowheads), were densely packed, and had
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typical red birefringence when compared with NaCl-treated
mice, with no significant differences between control and
MC-depleted mice (Figure 6c). We further assessed the
biochemical nature of collagen fibril crosslinks formed in
bleomycin-induced skin lesions in MC-depleted versus control
mice. IL-4 has been shown to be a potent inducer of fibrosis-
associated collagen crosslinks (Brinckmann et al., 2005) and
we speculated that MCs may be a source for IL-4 in fibrotic
tissues. For this purpose, the amount of fibrosis-associated
crosslinks hydroxylysyl pyridinoline and dihydroxylysino-
norleucine and the amount of healthy skin–associated
crosslinks histidino-hydroxylysinonorleucine and hydroxylysi-
nonorleucine were determined in fibrotic tissue (Figure 6d).
Findings revealed a robust increase in the ratio of hydroxylysyl
pyridinoline and dihydroxylysinonorleucine to histidino-
hydroxylysinonorleucine and hydroxylysinonorleucine within
fibrotic lesions of control and MC-depleted mice when
compared with untreated and NaCl-treated control skin
(Figure 6d). No significant difference between control and
MC-depleted mice was detected (Figure 6d).
DISCUSSION
The unresolved functional role of MCs in skin repair and
fibrosis as well as the discovery of effects in KitW/Wv mutants
not related to their MC deficiency led us to initiate studies to
reevaluate MC functions in skin repair and fibrosis. Here we
used the recently developed MC-specific Mcpt5Cre mouse
line to follow the kinetics and the spatial distribution of MCs
accumulating at the site of skin damage in a Mcpt5Cre/eYFP
reporter mouse model. Our analysis showed that MCs
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Figure 6. Genetic ablation of mast cells (MCs) fails to prevent skin fibrosis in mice. (a) Analysis of dermal thickness in bleomycin-induced fibrotic lesions (H&E
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red–stained and in polarized light analyzed skin sections; arrowheads indicate thick collagen bundles within fibrotic lesions; bar¼ 50mm. (d) Analysis of
collagen crosslink formation in skin samples; depicted is the ratio of HPþDHLNL to HHLþHLNL crosslinks. (b, d) Each dot represents the fibrotic lesion
per mouse (n¼ 3–8 mice per group and time point). *Po0.05, **Po0.01, ***Po0.001. d, dermis; DHLNL, dihydroxylysinonorleucine; e, epidermis; he,
hyperproliferative epidermis; H&E, hematoxylin and eosin; HHL, histidino-hydroxylysinonorleucine; HLNL, hydroxylysinonorleucine; HP, hydroxylysyl
pyridinoline; pc, panniculus carnosus; sf, subcutaneous fat tissue.
S Willenborg et al.
Mast Cells in Skin Repair
2012 Journal of Investigative Dermatology (2014), Volume 134
accumulate both at the site of excision injury and repair and in
bleomycin-induced fibrotic skin lesions. In both models, we
found a distinct difference in the kinetic and the spatial
distribution of MC accumulation between the actual site of
skin injury/repair and the skin adjacent to the damaged lesion.
Increased MC numbers are initially detectable particularly at
the edge of the injured tissue, followed by an increase within
the actual site of repair (granulation tissue) or fibrotic lesion. At
this stage we can only speculate on the mechanism underlying
this particular spatial distribution of MC accumulation follow-
ing skin injury and restoration of tissue integrity. MCs in skin
wounds might originate from MC precursors circulating in the
blood stream as described by Rodewald et al. (1996). How-
ever, as in vitro studies suggest, in addition/alternatively, hair
follicles that are present at wound margins may serve as a
reservoir for skin MC precursors (Kumamoto et al., 2003). We
did not detect proliferating MCs at any stage of the healing
response or in any area of the wound tissue (data not shown),
supporting the concept of active recruitment of MC precursors
into the wound site.
In this study we used the Mcpt5Cre mouse line to generate a
mouse model of DT-inducible ablation of connective
tissue–type MCs. We show that a combination of repetitive
i.p. and i.d. DT injections leads to significant MC ablation
during the processes of skin repair and bleomycin-induced
skin fibrosis. Findings in the excision skin injury model
convincingly showed that MC ablation did not critically affect
wound closure kinetics. Hence, it is unlikely that the increased
distance between the ends of the panniculus carnosus 3 days
after injury in MC-depleted mice reflects reduced wound
contraction due to attenuated myofibroblast differentiation.
Our findings rather suggest that activated tissue-resident MCs
located adjacent to the damaged skin release mediators that
may act directly on the contractility of the panniculus
carnosus. In rodents, contraction of the panniculus carnosus
is supposed to contribute to overall wound closure (Galiano
et al., 2004), particularly during the early phase of repair.
However, this process does not significantly contribute to the
proliferative phase of the healing response (meaning effective
tissue growth and cell proliferation). Furthermore, humans do
not have a panniculus carnosus and contraction of this skin
muscle is of minor importance when investigating repair
mechanisms with potential clinical consequences.
Although here we show that connective tissue MCs can be
virtually entirely ablated in nonchallenged skin in Mcpt5Cre/
iDTR mice, in experimentally challenged skin lesions, mini-
mal numbers of sporadic MCs were detectable during the late-
stage healing response and bleomycin-induced fibrosis, and
may raise the question of whether these residual MCs
mediated the healing/fibrotic response. However, here we
showed that neither a mild (42.3±13.5%) nor a severe
(85.4±6.1%) reduction of MCs in the injured tissue affects
the healing response, thereby arguing against this concern. In
addition, recent studies, exploring skin repair in a different
genetic mouse model of MC-ablation, did not detect signifi-
cant alterations during the healing response in the absence
of MCs (Antsiferova et al., 2013; Nauta et al., 2013).
Furthermore, it is noteworthy to mention that in the
previously studied W/Wv mice, few MCs are present in
normal and, particularly, in inflamed skin (Waskow et al.,
2007; Feyerabend et al., 2011). Collectively, these findings
provide arguments that differences observed between W/Wv
mice and the recently developed genetic mouse model are
very likely to reflect non-MC-specific effects.
To test the hypothesis of whether MCs have nonredundant
functions on the extent and/or the quality of fibrosis develop-
ment, we employed two independent approaches. First, we
analyzed formation of fibrosis in a physiological process, e.g.,
scar formation following excision skin injury and repair.
Earlier in vitro studies have demonstrated that MC-derived
mediators, in particular tryptase, exert profibrotic effects by
stimulating proliferation and collagen synthesis in human
fibroblasts isolated from various organs (Cairns and Walls,
1997; Kondo et al., 2001; Garbuzenko et al., 2002).
Furthermore, systemic Ketotifen treatment has been shown
to attenuate excessive scar contraction in excisional skin
wounds in pigs, suggesting a role of MCs in wound-induced
scar formation and contraction (Gallant-Behm et al., 2008).
Ketotifen is a well-known stabilizer of MCs, but more recently
additional anti-inflammatory effects have been discussed that
may affect scar formation (Lambiase et al., 2009). Our studies
indicate that the amount of scar tissue and the overall
organization of collagen fibers were not altered in MC-
depleted mice. Our findings are in line with observations by
Egozi et al. (2003) reporting on similar hydroxyproline levels
in scar tissue of control and KitW/Wv mice. In contrast, Iba et al.
(2004) report on higher levels of hydroxyproline in excision
wounds of KitW/Wv mice compared with controls, although the
underlying mechanisms remain obscure in this study. Apart
from a minor role of MC-derived mediators in the healing
response, another possible explanation for nonaltered scar
tissue in MC-depleted Mcpt5Cre/iDTR mice may be that the
loss of profibrotic MC-derived mediators can be compensated
by other (inflammatory and/or noninflammatory) cell types
being more abundant at the wound site (e.g., macrophages). In
addition, we also examined fibrosis development in a
pathological condition, e.g., bleomycin-induced skin fibrosis.
Bleomycin-induced skin fibrosis is a well-established disease
model for skin sclerosis, although the basic mechanisms are
not yet completely understood (Yamamoto and Nishioka,
2005). It is speculated that bleomycin provokes an
inflammatory response inducing skin fibrosis (Yamamoto and
Nishioka, 2005). As shown in this study and earlier by others,
MCs accumulate in bleomycin-induced fibrosis and thus
may contribute to its pathology (Yamamoto et al., 1999a).
Yamamoto et al. (1999b) challenged the skin of KitW/Wv mice
with bleomycin and showed that MCs are not required for the
development of skin fibrosis. In our study we used
the same model of bleomycin-induced skin fibrosis and did
not detect any biochemical or structural difference in fibrosis
development under conditions of severe reduction of MC
numbers. Thus, our findings in MC-depleted Mcpt5Cre/iDTR
mice corroborate the observation in KitW/Wv mice that MCs do
not affect the development of skin fibrosis in the examined
physiological and pathological conditions in mice. However,
we wish to point out that our findings cannot rule out that
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alterations in scar formation that can be observed after months
and years of injury in humans such as hypertrophic scars
and keloids, or even fibrosis in other organs than the skin, e.g.
the lung (Veerappan et al., 2013), are at least in part mediated
by MCs.
Conclusively, this study shows that the Mcpt5Cre/iDTR
mouse represents a valuable model to study functions of
MCs in skin repair and fibrosis in vivo. Although at this stage
we cannot exclude that lack of MCs in Mcpt5Cre/iDTR mice
may be compensated by factors released from other cell types,
our findings provide strong evidence that severe reduction of
tissue-resident MCs does not affect the proper kinetics of skin
repair and the development of skin fibrosis. Thus, our findings
point out to carefully revisit the concept of MCs as promising
target for therapeutic intervention in wound healing or fibrotic
pathologies.
MATERIALS AND METHODS
Mice
Mcpt5Cre/iDTR mice (Buch et al., 2005; Scholten et al., 2008) and
Mcpt5Cre/eYFP reporter mice (Srinivas et al., 2001) were generated
and genotyped by PCR as described earlier. Mice were used at the
age of 10–12 weeks and housed in specific pathogen-free conditions.
Mcpt5Cre/iDTR and iDTR littermates received repetitive i.p. injec-
tions of 25 ng DT per g bodyweight (Sigma-Aldrich, St Louis, MO) as
indicated. All procedures were in accordance with institutional
guidelines on animal welfare and were approved by the North
Rhine-Westphalia State Environment Agency, Germany.
Wounding and preparation of wound tissue
Wounding and preparation of wound tissue for histology was
performed as recently described (Lucas et al., 2010). Briefly, mice
were anesthetized and full-thickness, circular wounds (6 mm punch
biopsies) were created on the back. Mice were housed individually
during the entire time course of healing. For histological analysis,
wounds were excised at indicated time points after injury, bisected
exactly in the center of the wound in caudocranial direction, and the
tissue was either fixed overnight in 4% formalin or embedded in
Optimal Cutting Temperature (OCT) compound (Sakura Finetek
Europe B.V., Alphen aan den Rijn, The Netherlands); corresponding
serial sections of wound tissue in controls and MC-depleted mice
were compared. To assure exact and reproducible dissection in the
center of the wound, wound edges were tattooed appropriately at the
time of wounding. To increase MC ablation efficiency, Mcpt5Cre/
iDTR and control mice received after injury one i.p. DT injection (day
2 after injury) and one i.d. DT injection at the wound edge (5 ng per
wound in 50ml phosphate-buffered saline) (day 9 after injury).
Induction of skin fibrosis by bleomycin
To evaluate the role of MCs during the development of skin fibrosis,
we used an established scleroderma mouse model (Yamamoto et al.,
1999a). Mice received daily i.d. injections with 100mg of bleomycin.
Tissues were fixed in 4% formalin or embedded in OCT compound
(Tissue Tek).
Flow cytometric analysis
Wound cells were isolated by a combination of enzymatic digestion
(Liberase blendzyme, Roche Applied Science, Penzberg, Germany)
and mechanical disruption (BD Medimachine System, BD Biosciences,
San Diego, CA). For FACS analysis, Fc receptors were blocked with
mouse seroblock FcR (CD16/CD32, eBioscience, San Diego, CA) and
cells were stained with phycoerythrin-conjugated anti-IgE (eBioscience),
allophycocyanin (APC)-conjugated anti-c-kit (eBioscience), phycoery-
thrin-conjugated anti-F4/80 (AbD Serotec, Oxford, UK), APC-conjugated
anti-CD11b (Miltenyi Biotech, Bergisch Gladbach, Germany), APC-
eFluor780-conjugated anti-CD45 (eBioscience), or APC-cyanine7-
conjugated anti-Ly6G (BD Biosciences). Cells were incubated with
antibodies (30minutes, 4 1C) and washed 3 times thereafter in washing
buffer (1% BSA, 2mM EDTA in phosphate-buffered saline). Dead cells
were excluded by using 7-Amino-Actinomycin D (BD Biosciences).
Cells were analyzed using a FACSCanto II flow cytometer and the
FACSDiva Software Version 6.1.1 (BD Biosciences).
Immunohistochemistry
Cryosections (10mm) were fixed and incubated with primary (APC-
conjugated anti-c-kit (eBioscience), anti-eYFP (Life Technologies,
Carlsbad, CA), and Cy3-coupled anti-a-smooth muscle actin (Sigma))
and secondary (Alexa488-conjugated (Life Technologies)) antibodies.
The 4’,6-diamidino-2-phenylindole serves as counterstain (Life Tech-
nologies). Images were acquired using Nikon Eclipse E800 and
Olympus DeltaVision with NIS-Elements AR 2.30 Software (Nikon,
Tokyo, Japan) or Softworx Suite 2.0 software (Olympus, Tokyo,
Japan), processed with Adobe Photoshop 7.0 (Adobe Systems,
San Jose, CA), and analyzed with ImageJ (Image Processing and
Analysis in Java, National Institute of Mental Health, Bethesda, MD).
Morphometric analysis
Morphometric analysis was performed on hematoxylin and eosin–
stained tissue sections using light microscopy (Leica DM4000B,
Leica, Wetzlar, Germany) at indicated magnifications as recently
described (Lucas et al., 2010). Staining for a-smooth muscle actin
was quantified in high-power fields (7,000 5,500mm2) within
granulation tissue using ImageJ software. Analyses were performed
in a blinded manner by two independent investigators.
Analysis of collagen crosslinks
Analysis of collagen crosslinks was performed using an amino acid
analyzer (Biochrom 30, Merck Millipore, Darmstadt, Germany) as
previously described (Brinkmann et al., 2005) (for detailed
information see Supplementary Material and Methods online).
Statistical analysis
Significance of difference was analyzed using Student’s unpaired two-
tailed t-test or analysis of variance one-way analysis with Tukey’s
multiple comparison test. Data are presented as means, and a P-value
ofo0.05 was considered significant. Significance levels are indicated
in each figure.
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